Investigating the role of EZH2 as a therapeutic target in clear cell renal cell carcinoma (ccRCC)

被引：0
|
作者：
Wei, Darmood
Ricketts, Christopher J.
Schmidt, Laura S.
Yang, Youfeng
Vocke, Cathy D.
Linehan, William M.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-4707
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4707
引用
收藏
页数：3
相关论文
共 50 条
  • [41] ERK5 IS A PROMISING THERAPEUTIC TARGET FOR CLEAR CELL RENAL CELL CARCINOMA
    Kanno, Hidenori
    Naito, Sei
    Ichiyanagi, Osamu
    Narisawa, Takahumi
    Ito, Hiromi
    Nagaoka, Akira
    Ito, Suguru
    Suenaga, Shinta
    Fukuhara, Hiroki
    Kurota, Yuta
    Yagi, Mayu
    Yamagishi, Atsushi
    Sakurai, Toshihiko
    Nishida, Hayato
    Kawazoe, Hisashi
    Abe, Akihiko
    Yamanobe, Takuya
    Kato, Tomoyuki
    Tsuchiya, Norihiko
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1204 - E1204
  • [42] De-clear cell differentiated renal cell carcinoma - a new therapeutic target
    Lawson, Keith A.
    Linehan, W. Marston
    NATURE REVIEWS UROLOGY, 2025, 22 (02) : 73 - 74
  • [43] Role of the EZH2 histone methyltransferase as a therapeutic target in cancer
    Italiano, Antoine
    PHARMACOLOGY & THERAPEUTICS, 2016, 165 : 26 - 31
  • [44] Transcriptional (mRNA) Profiling in Clear Cell Renal Cell Carcinoma (CCRCC): Comparison of CCRCC to Non-Neoplastic Renal Tissue
    Bastacky, S. I.
    Bastacky, M. L.
    Roy, S.
    Parwani, A. V.
    Dhir, R.
    Lyons-Weiler, M. A.
    Sciulli, C. M.
    Krill-Burger, M.
    Amin, M.
    LaFramboise, W. A.
    LABORATORY INVESTIGATION, 2013, 93 : 196A - 196A
  • [45] SETD2, a histone methyltransferase, is misregulated in advanced clear cell renal cell carcinoma (ccRCC)
    Ho, T. H.
    Monzon, F. A.
    Hoang, A.
    Hung, M. C.
    Jonasch, E.
    BJU INTERNATIONAL, 2012, 109 : 1 - 2
  • [46] Transcriptional (mRNA) Profiling in Clear Cell Renal Cell Carcinoma (CCRCC): Comparison of CCRCC to Non-Neoplastic Renal Tissue
    Bastacky, S. I.
    Bastacky, M. L.
    Roy, S.
    Parwani, A. V.
    Dhir, R.
    Lyons-Weiler, M. A.
    Sciulli, C. M.
    Krill-Burger, M.
    Amin, M.
    LaFramboise, W. A.
    MODERN PATHOLOGY, 2013, 26 : 196A - 196A
  • [47] SETD2, a histone methyltransferase, is misregulated in advanced clear cell renal cell carcinoma (ccRCC)
    Ho, Thai H.
    Monzon, Federico A.
    Anh Hoang
    Tamboli, Pheroze
    Furge, Kyle
    Dykema, Karl
    Petillo, David
    Teh, Bin Tean
    Tannir, Nizar
    Jonasch, Eric
    Hung, Mien-Chie
    CANCER RESEARCH, 2012, 72
  • [48] Molecular characterization of SETD2, a histone methyltransferase, in clear cell renal cell carcinoma (ccRCC)
    Thai Huu Ho
    Monzon, Federico A.
    Hoang, Anh
    Tamboli, Pheroze
    Furge, Kyle A.
    Dykema, Karl
    Petillo, David
    Teh, Bin Tean
    Tannir, Nizar M.
    Hung, Mien-Chie
    Jonasch, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [49] Ailanthone suppresses cell proliferation of renal cell carcinoma partially via inhibition of EZH2
    Zhu, Jianbing
    Dai, Guangcheng
    Chen, Ting
    Zhou, Yibin
    Zang, Yachen
    Xu, Lijun
    Jin, Lu
    Zhu, Jin
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [50] Angiopoietin 2 (Ang-2) as prognosis biomarker in clear cell renal cell carcinoma (ccRCC) patients
    Boggio, G.
    Knott, M. E.
    Grasselli, J.
    Gandur Quiroga, M. N.
    Pasik, L.
    Gueglio, G.
    Pulero, C.
    Alvarez, A.
    Puricelli, L.
    Pallotta, M. G.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S677 - S677
12345